Viewing StudyNCT00443573

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 5:23 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00443573
Status: SUSPENDED
Last Update Posted: 2008-05-07
First Post: 2007-03-02
Brief Title: Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer
Sponsor: ARCA Biopharma Inc
Organization: ARCA Biopharma Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Colon Cancer
Keywords:
Name View
metastatic colorectal carcinoma mCRC View
colorectal carcinoma CRC View
tissue factor View
factor VIIa View
rNAPc2 View
adenocarcinoma View
targeted therapy View
coagulation-dependent View
RECIST View
5-FU-based chemotherapy View
FOLFOX View
FOLFIRI View
leucovorin View
XELOX View